Jean P. Cornet

Array ( [id] => 17640538 [patent_doc_number] => 20220168276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate [patent_app_type] => utility [patent_app_number] => 16/985789 [patent_app_country] => US [patent_app_date] => 2020-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16452506 [patent_doc_number] => 20200361932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT [patent_app_type] => utility [patent_app_number] => 16/944265 [patent_app_country] => US [patent_app_date] => 2020-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16944265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19241007 [patent_doc_number] => 12011423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders [patent_app_type] => utility [patent_app_number] => 16/944137 [patent_app_country] => US [patent_app_date] => 2020-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8943 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16944137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18595965 [patent_doc_number] => 20230270755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMBINATION OF MEDICATIONS IN A PARENTERAL DOSAGE FORM FOR LONG-TERM ANAESTHESIA [patent_app_type] => utility [patent_app_number] => 18/017860 [patent_app_country] => US [patent_app_date] => 2020-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18018969 [patent_doc_number] => 20220370468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => Methods of treating sleep disorders associated with pain [patent_app_type] => utility [patent_app_number] => 17/627993 [patent_app_country] => US [patent_app_date] => 2020-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17851832 [patent_doc_number] => 20220281874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/628794 [patent_app_country] => US [patent_app_date] => 2020-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -113 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17851832 [patent_doc_number] => 20220281874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/628794 [patent_app_country] => US [patent_app_date] => 2020-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -113 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16523642 [patent_doc_number] => 20200397722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => EPINEPHRINE SPRAY FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/930386 [patent_app_country] => US [patent_app_date] => 2020-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16930386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16512904 [patent_doc_number] => 20200392162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => CHROMENOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINSITOL PHOSPHATE KINASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/904064 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13516 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17881083 [patent_doc_number] => 20220296560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION IN POWDER FORMULATION CONTAINING ANTIVIRAL AGENT [patent_app_type] => utility [patent_app_number] => 17/596585 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17272827 [patent_doc_number] => 20210379025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => COMPOSITIONS AND METHODS FOR BLOCKING THE CYTOKINE STORM OF CORONAVIRUS AND OTHER MEDICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/946105 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18128827 [patent_doc_number] => 11555026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-17 [patent_title] => AHR inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 16/890196 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38931 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17783530 [patent_doc_number] => 11406632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Aripiprazole formulations having increased injection speeds [patent_app_type] => utility [patent_app_number] => 16/889528 [patent_app_country] => US [patent_app_date] => 2020-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13493 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17749600 [patent_doc_number] => 20220227804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => COMBINATION OF A POLYHYDROXYLATED BILE ACID AND A FARNESOID X RECEPTOR AGONIST [patent_app_type] => utility [patent_app_number] => 17/614679 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16310736 [patent_doc_number] => 20200289474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC [patent_app_type] => utility [patent_app_number] => 16/886074 [patent_app_country] => US [patent_app_date] => 2020-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17718942 [patent_doc_number] => 20220211661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => GREEN TEA CATECHINS EUTECTIC SYSTEM [patent_app_type] => utility [patent_app_number] => 17/595076 [patent_app_country] => US [patent_app_date] => 2020-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10777 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20402202 [patent_doc_number] => 12492170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 17/614780 [patent_app_country] => US [patent_app_date] => 2020-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5090 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17911307 [patent_doc_number] => 20220313702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => OXATHIAZIN COMPOUNDS FOR INHIBITING GAPDH [patent_app_type] => utility [patent_app_number] => 17/612950 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17733258 [patent_doc_number] => 20220218717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => PROCESS FOR MANUFACTURING SOFT CHEWABLE FREE FLOWING GRANULES AND COMPANION ANIMAL PRODUCTS THEREOF [patent_app_type] => utility [patent_app_number] => 17/595636 [patent_app_country] => US [patent_app_date] => 2020-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17733165 [patent_doc_number] => 20220218624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => INCLUSION COMPOUND CONTAINING NON-PSYCHOACTIVE CANNABINOID AND METHOD FOR PREPARTION THEREOF [patent_app_type] => utility [patent_app_number] => 17/594608 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594608 [rel_patent_id] =>[rel_patent_doc_number] =>)